Lilly Completes Acquisition Of Novartis Animal Health
Eli Lilly and Company (NYSE: LLY) yesterday announced that it has completed the acquisition of Novartis Animal Health, which will further position Lilly’s Elanco as a global leader in the animal health industry. The transaction, first announced on April 22, has received clearance under the Hart-Scott-Rodino Antitrust Improvements … Read More